These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11225756)

  • 21. [Hyperglycemia and atherosclerosis].
    Wautier JL
    Journ Annu Diabetol Hotel Dieu; 2000; ():107-12. PubMed ID: 10932873
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is macroangiopathy a complication of diabetes mellitus? I.Hyper- insulinemia].
    Goldsztajn P
    Przegl Lek; 1990; 47(7):551-6. PubMed ID: 2284423
    [No Abstract]   [Full Text] [Related]  

  • 23. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.
    Dandona P; Aljada A; Chaudhuri A; Bandyopadhyay A
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2422-9. PubMed ID: 12788837
    [No Abstract]   [Full Text] [Related]  

  • 24. Diabetes and atherosclerosis--a lipoprotein perspective.
    Steiner G
    Diabet Med; 1997 Aug; 14 Suppl 3():S38-44. PubMed ID: 9272612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does hyperglycemia really cause coronary heart disease?
    Barrett-Connor E
    Diabetes Care; 1997 Oct; 20(10):1620-3. PubMed ID: 9314646
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epidemiology of the complication of coronary atherosclerosis: some results of the prospective Paris study].
    Ducimetière P; Richard J; Eschwege E; Claude J; Rosselin G
    Journ Annu Diabetol Hotel Dieu; 1982; ():257-64. PubMed ID: 7098251
    [No Abstract]   [Full Text] [Related]  

  • 27. Diet, diabetes and atherosclerosis.
    Raheja BS
    J Assoc Physicians India; 1990 Feb; 38(2):168-72. PubMed ID: 2199427
    [No Abstract]   [Full Text] [Related]  

  • 28. Macroangiopathy--its prevalence in asymptomatic diabetes.
    Keen H; Jarrett RJ
    Adv Metab Disord; 1973; 2():Suppl 2:3-9. PubMed ID: 4720377
    [No Abstract]   [Full Text] [Related]  

  • 29. Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Bell DS
    Acta Diabetol; 2009 Jun; 46(2):155; author reply 157. PubMed ID: 19300899
    [No Abstract]   [Full Text] [Related]  

  • 30. Are there specific components of the insulin resistance syndrome that predict the increased atherosclerosis seen in type 2 diabetes mellitus?
    Golden SH; Chong R
    Curr Diab Rep; 2004 Feb; 4(1):26-30. PubMed ID: 14764276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes and atherosclerosis. Physiopathology of diabetic macroangiopathy].
    Leutenegger M
    Rev Med Interne; 1994; 15 Suppl 3():270S-273S. PubMed ID: 7863131
    [No Abstract]   [Full Text] [Related]  

  • 32. Atherosclerosis, the major complication of diabetes.
    Steiner G
    Adv Exp Med Biol; 1985; 189():277-97. PubMed ID: 4036715
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxicity of hyperglycaemia in type 2 diabetes.
    Yki-Järvinen H
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S45-50. PubMed ID: 9816487
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].
    Igarashi Y; Kawamori R
    Nihon Rinsho; 2006 Nov; 64(11):1998-2004. PubMed ID: 17087289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus.
    Pyörälä K; Uusitupa M; Laakso M; Siitonen O; Niskanen L; Rönnemaa T
    Diabete Metab; 1987 Jul; 13(3 Pt 2):345-9. PubMed ID: 3308562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors.
    Temelkova-Kurktschiev TS; Koehler C; Leonhardt W; Schaper F; Henkel E; Siegert G; Hanefeld M
    Diabetes Care; 1999 Feb; 22(2):333-8. PubMed ID: 10333954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Validity of the Framingham-REGICOR and DORICA coronary risk equations for a health centre's diabetic population].
    Cañón Barroso L; Cruces Muro E; Fernández Gómez A; Buitrago Ramírez F
    Aten Primaria; 2006 Sep; 38(4):241-2. PubMed ID: 16978567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing the epidemiology of and interrelations between atherosclerosis and diabetes mellitus.
    Pfeiffer EF
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():425-8. PubMed ID: 5146915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Macro- and microangiopathy in the elderly diabetics].
    Ito H
    Nihon Ronen Igakkai Zasshi; 1992 Jun; 29(6):449-56. PubMed ID: 1527901
    [No Abstract]   [Full Text] [Related]  

  • 40. [Profile of the main risk factors of arteriosclerosis in patients with diabetes mellitus].
    Tatoń J; Walewski J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):3-7. PubMed ID: 1409038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.